Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Marketwatch
Fri, 08/29/08 - 06:34 am
Judge rules J&J drug patent is invalid
Star Ledger, NJ
Fri, 08/29/08 - 06:31 am
Stent Probe Undermines J&J, Abbott, Boston Scientific Target
Bloomberg
Fri, 08/29/08 - 06:29 am
A Big Upgrade for Eli Lilly
Motley Fool
Thu, 08/28/08 - 05:08 pm
Schering and Pfizer Aren't Horsing Around
Motley Fool
Thu, 08/28/08 - 05:07 pm
Me-Too Drugs: Are They Worth It?
Motley Fool
Thu, 08/28/08 - 05:06 pm
Affymax, Takeda narrow Hematide focus
Bizjournals.com
Thu, 08/28/08 - 05:05 pm
Buy! Sell! Analysts Duke It Out Over Amylin
WSJ Online
Thu, 08/28/08 - 05:02 pm
The Vioxx ‘V’ Squad: Reps From Another Universe
Pharmalot
Thu, 08/28/08 - 05:00 pm
Amylin Pharmaceuticals shares recover some sharp losses following new Byetta deaths
Yahoo/AP
Thu, 08/28/08 - 12:53 pm
Valeant and GlaxoSmithKline enter worldwide collaboration agreement for retigabine
RTT News
Thu, 08/28/08 - 11:11 am
Merck's Charm Offensive
CNBC
Thu, 08/28/08 - 11:10 am
BDSI gets good news on drug, though approval is delayed
Bizjournals.com
Thu, 08/28/08 - 10:54 am
J&J to appeal Razadyne patent ruling
Marketwatch
Thu, 08/28/08 - 10:53 am
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE
Yahoo/AP
Thu, 08/28/08 - 09:21 am
Report: Medicare Pays Too Much for Some New Generics
WSJ Online
Thu, 08/28/08 - 08:09 am
Pfizer Is Worth Another Look
Seeking Alpha
Thu, 08/28/08 - 08:08 am
Amgen to Stop Offering Discounts on Anemia Drug
New York Times, NY
Thu, 08/28/08 - 08:00 am
CROs: The 'Big Pharma Effect'
Seeking Alpha
Thu, 08/28/08 - 07:58 am
Amgen to discontinue discounts on anemia drug: report
Yahoo/Reuters
Thu, 08/28/08 - 06:33 am

Pages